X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (685) 685
Newsletter (38) 38
Publication (21) 21
Newspaper Article (9) 9
Book Review (8) 8
Book Chapter (3) 3
Conference Proceeding (2) 2
Magazine Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
palonosetron (683) 683
nausea (315) 315
humans (293) 293
index medicus (292) 292
chemotherapy (252) 252
oncology (235) 235
prevention (233) 233
cancer (222) 222
double-blind (212) 212
vomiting (209) 209
vomiting - chemically induced (196) 196
ondansetron (189) 189
dexamethasone (187) 187
female (184) 184
nausea - chemically induced (182) 182
moderately emetogenic chemotherapy (177) 177
antiemetics - therapeutic use (172) 172
middle aged (169) 169
aprepitant (160) 160
male (156) 156
adult (154) 154
vomiting - prevention & control (153) 153
chemotherapy-induced nausea and vomiting (138) 138
nausea - prevention & control (138) 138
efficacy (134) 134
aged (130) 130
isoquinolines - therapeutic use (130) 130
quinuclidines - therapeutic use (130) 130
antineoplastic agents - adverse effects (128) 128
phase-iii (120) 120
medicine & public health (110) 110
antiemetics (109) 109
chemotherapy-induced nausea (102) 102
pharmacology & pharmacy (102) 102
health care sciences & services (97) 97
granisetron (91) 91
isoquinolines - administration & dosage (90) 90
quinuclidines - administration & dosage (90) 90
care and treatment (88) 88
pain medicine (82) 82
nursing (80) 80
rehabilitation (80) 80
research (80) 80
cinv (76) 76
safety (76) 76
vomiting - drug therapy (76) 76
treatment outcome (74) 74
antiemetics - administration & dosage (73) 73
rehabilitation medicine (73) 73
nausea - drug therapy (71) 71
receptor antagonist (71) 71
trial (69) 69
drug therapy (66) 66
health aspects (65) 65
complications and side effects (64) 64
dexamethasone - therapeutic use (63) 63
dosage and administration (63) 63
analysis (62) 62
emesis (62) 62
isoquinolines - adverse effects (62) 62
quinuclidines - adverse effects (62) 62
double-blind method (60) 60
neoplasms - drug therapy (60) 60
netupitant (60) 60
postoperative nausea and vomiting (58) 58
5-ht3 receptor antagonist (57) 57
original (56) 56
antiemetics - adverse effects (55) 55
drug therapy, combination (55) 55
induced nausea (55) 55
placebo-controlled trial (55) 55
antineoplastic combined chemotherapy protocols - adverse effects (54) 54
serotonin antagonists - therapeutic use (54) 54
gastrointestinal agents (51) 51
prophylaxis (51) 51
nursing management/nursing research (49) 49
risk factors (49) 49
highly emetogenic chemotherapy (47) 47
surgery (47) 47
cancer therapies (46) 46
cisplatin (46) 46
dexamethasone - administration & dosage (46) 46
patients (46) 46
5-ht (45) 45
clinical trials (44) 44
guideline update (44) 44
prospective studies (44) 44
young adult (43) 43
dolasetron (41) 41
morpholines - therapeutic use (41) 41
nepa (39) 39
5-ht3 receptor antagonists (38) 38
antiemetic (38) 38
antineoplastic agents (38) 38
cisplatin - adverse effects (37) 37
original article (37) 37
olanzapine (36) 36
5-ht3 receptor (35) 35
anesthesiology (35) 35
antineoplastic combined chemotherapy protocols - therapeutic use (35) 35
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (712) 712
Korean (14) 14
German (3) 3
Japanese (2) 2
Portuguese (2) 2
Spanish (2) 2
Arabic (1) 1
French (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Pharmacology, ISSN 0014-2999, 06/2012, Volume 684, Issue 1-3, pp. 1 - 7
Nausea and vomiting are among the most common and distressing consequences of cytotoxic chemotherapies. Nausea and vomiting can be acute (0-24 h) or delayed... 
Granisetron | receptor | Netupitant | 5-HT | Ondansetron | Palonosetron
Journal Article
Journal of Clinical Anesthesia, ISSN 0952-8180, 2016, Volume 34, pp. 459 - 482
Journal Article
Experimental Brain Research, ISSN 0014-4819, 08/2014, Volume 232, Issue 8, p. 2637
Current therapy for chemotherapy-induced nausea and vomiting includes the use of both [5-HT.sub.3] and N[K.sub.1] receptor antagonists. Acute emesis has... 
Physiological aspects | Research | Analysis | Palonosetron
Journal Article
Journal Article
Journal Article
Oncologist, ISSN 1083-7159, 2019, p. theoncologist.2019-0133
A dexamethasone-sparing regimen consisting of palonosetron plus 1-day dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) has... 
Moderately emetogenic chemotherapy | Nausea | Dexamethasone | Vomiting | Chemotherapy-induced nausea and vomiting | Palonosetron
Journal Article
Journal of Gynecologic Oncology (JGO), ISSN 2005-0380, 2018, Volume 29, Issue 5, p. 1
Objective: Palonosetron is effective for the management of acute and delayed chemotherapy-induced nausea and vomiting (CINV). While emetogenic... 
Gynecologic Neoplasm | Vomiting | Carboplatin | Nausea | Palonosetron
Journal Article
International Journal of Clinical and Experimental Medicine, 2016, Volume 9, Issue 12, pp. 22963 - 22968
Journal Article
SUPPORTIVE CARE IN CANCER, ISSN 0941-4355, 01/2018, Volume 26, Issue 1, pp. 269 - 274
Few studies have investigated the effect of palonosetron on delayed chemotherapy-induced nausea and vomiting in lymphoma patients receiving the CHOP regimen.... 
TRIAL | CHEMOTHERAPY-INDUCED NAUSEA | ONCOLOGY | MODERATELY EMETOGENIC CHEMOTHERAPY | Chop | PHASE-III | HEALTH CARE SCIENCES & SERVICES | SINGLE-DOSE PALONOSETRON | REHABILITATION | Non-Hodgkin's lymphoma | Palonosetron | Medical colleges | Medical research | Chemotherapy | Medicine, Experimental | Nausea | Non-Hodgkin's lymphomas | Vincristine | Cancer
Journal Article
Chinese Journal of Clinical Oncology, ISSN 1000-8179, 10/2014, Volume 41, Issue 20, pp. 1323 - 1327
Journal Article
Current Therapeutic Research, ISSN 0011-393X, 2019, Volume 91, pp. 17 - 21
Postoperative nausea and vomiting (PONV) are 2 of the most frequent adverse effects of anesthesia. PONV prolongs hospital stays and also delays the recovery of... 
Tropisetron | Nausea | Vomiting | Ondansetron | Ear | Palonosetron
Journal Article
Journal Article
Anesthesia & Analgesia, ISSN 0003-2999, 04/2018, Volume 126, Issue 4, pp. 1353 - 1361
BACKGROUND:The optimal regional technique for analgesia and improved quality of recovery after video-assisted thoracic surgery (a procedure associated with... 
SINGLE-INJECTION | TRIAL | ANESTHESIA | QOR-40 | DEXAMETHASONE | PAIN | STELLATE GANGLION BLOCKADE | ANESTHESIOLOGY | REGIONAL ANALGESIA | THORACOSCOPIC SURGERY | PARAVERTEBRAL BLOCK
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 01/2010, Volume 626, Issue 2-3, pp. 193 - 199
Palonosetron is a 5-HT receptor antagonist that has demonstrated superiority in preventing both acute and delayed emesis when compared to older first... 
Receptor internalization | Granisetron | receptor | 5-HT | Ondansetron | Palonosetron | CELLS | ANTAGONIST | CHEMOTHERAPY-INDUCED NAUSEA | PHASE-III TRIAL | MODERATELY EMETOGENIC CHEMOTHERAPY | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | LIGAND | BINDING | 5-HT3 receptor
Journal Article
Brazilian Journal of Anesthesiology, ISSN 0034-7094, 07/2017, Volume 67, Issue 4, pp. 337 - 341
Background Rocuronium causes pain and withdrawal movement during induction of anesthesia. In this study, palonosetron was investigated to have analgesic effect... 
Pain | Injection | Rocuronium | Withdrawal movement | Palonosetron
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 2019
To assess, from a United States (US) perspective, the cost-effectiveness of chemotherapy-induced nausea and vomiting (CINV) prophylaxis using a single dose of... 
CINV | Chemotherapy | Nausea | Cost-effectiveness | Netupitant and palonosetron | Antiemetic
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.